Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model

Abstract Human organic cation transporter 2 (hOCT2/SLC22A2) is a key drug transporter that facilitates the transport of endogenous and exogenous organic cations. Because hOCT2 is responsible for the development of adverse effects caused by platinum-based anti-cancer agents, drugs with OCT2 inhibitor...

Full description

Saved in:
Bibliographic Details
Main Authors: Fumihiro Yamane, Kenji Ikemura, Masayoshi Kondo, Manami Ueno, Masahiro Okuda
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-79377-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585814581706752
author Fumihiro Yamane
Kenji Ikemura
Masayoshi Kondo
Manami Ueno
Masahiro Okuda
author_facet Fumihiro Yamane
Kenji Ikemura
Masayoshi Kondo
Manami Ueno
Masahiro Okuda
author_sort Fumihiro Yamane
collection DOAJ
description Abstract Human organic cation transporter 2 (hOCT2/SLC22A2) is a key drug transporter that facilitates the transport of endogenous and exogenous organic cations. Because hOCT2 is responsible for the development of adverse effects caused by platinum-based anti-cancer agents, drugs with OCT2 inhibitory effects may serve as prophylactic agents against the toxicity of platinum-based anti-cancer agents. In the present study, we established a machine learning-based quantitative structure–activity relationship (QSAR) model for hOCT2 inhibitors based on the public ChEMBL database and explored novel hOCT2 inhibitors among the FDA-approved drugs. Using our QSAR model, we identified 162 candidate hOCT2 inhibitors among the FDA-approved drugs registered in the DrugBank database. After manual selection and in vitro assays, we found that dequalinium, a quaternary ammonium cation antimicrobial agent, is a potent hOCT2 inhibitor (IC50 = 88.16 ± 7.14 nM). Moreover, dequalinium inhibited hOCT2-mediated transport of platinum anti-cancer agents (cisplatin and oxaliplatin) in a concentration-dependent manner. Our study is the first to demonstrate the construction of a novel machine learning-based QSAR model for hOCT2 inhibitors and identify a novel hOCT2 inhibitor among FDA-approved drugs using this model.
format Article
id doaj-art-e6a540af88b749d3a6ee614b9476cba1
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e6a540af88b749d3a6ee614b9476cba12025-01-26T12:30:14ZengNature PortfolioScientific Reports2045-23222025-01-011511810.1038/s41598-024-79377-0Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR modelFumihiro Yamane0Kenji Ikemura1Masayoshi Kondo2Manami Ueno3Masahiro Okuda4Department of Hospital Pharmacy, School of Pharmaceutical Sciences, Osaka UniversityDepartment of Pharmacy, Osaka University HospitalDepartment of Hospital Pharmacy, School of Pharmaceutical Sciences, Osaka UniversityDepartment of Hospital Pharmacy, School of Pharmaceutical Sciences, Osaka UniversityDepartment of Pharmacy, Osaka University HospitalAbstract Human organic cation transporter 2 (hOCT2/SLC22A2) is a key drug transporter that facilitates the transport of endogenous and exogenous organic cations. Because hOCT2 is responsible for the development of adverse effects caused by platinum-based anti-cancer agents, drugs with OCT2 inhibitory effects may serve as prophylactic agents against the toxicity of platinum-based anti-cancer agents. In the present study, we established a machine learning-based quantitative structure–activity relationship (QSAR) model for hOCT2 inhibitors based on the public ChEMBL database and explored novel hOCT2 inhibitors among the FDA-approved drugs. Using our QSAR model, we identified 162 candidate hOCT2 inhibitors among the FDA-approved drugs registered in the DrugBank database. After manual selection and in vitro assays, we found that dequalinium, a quaternary ammonium cation antimicrobial agent, is a potent hOCT2 inhibitor (IC50 = 88.16 ± 7.14 nM). Moreover, dequalinium inhibited hOCT2-mediated transport of platinum anti-cancer agents (cisplatin and oxaliplatin) in a concentration-dependent manner. Our study is the first to demonstrate the construction of a novel machine learning-based QSAR model for hOCT2 inhibitors and identify a novel hOCT2 inhibitor among FDA-approved drugs using this model.https://doi.org/10.1038/s41598-024-79377-0DequaliniumDrug repositioningMachine learningOrganic cation transporter 2Quantitative structure-activity relationship
spellingShingle Fumihiro Yamane
Kenji Ikemura
Masayoshi Kondo
Manami Ueno
Masahiro Okuda
Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model
Scientific Reports
Dequalinium
Drug repositioning
Machine learning
Organic cation transporter 2
Quantitative structure-activity relationship
title Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model
title_full Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model
title_fullStr Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model
title_full_unstemmed Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model
title_short Identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based QSAR model
title_sort identification of dequalinium as a potent inhibitor of human organic cation transporter 2 by machine learning based qsar model
topic Dequalinium
Drug repositioning
Machine learning
Organic cation transporter 2
Quantitative structure-activity relationship
url https://doi.org/10.1038/s41598-024-79377-0
work_keys_str_mv AT fumihiroyamane identificationofdequaliniumasapotentinhibitorofhumanorganiccationtransporter2bymachinelearningbasedqsarmodel
AT kenjiikemura identificationofdequaliniumasapotentinhibitorofhumanorganiccationtransporter2bymachinelearningbasedqsarmodel
AT masayoshikondo identificationofdequaliniumasapotentinhibitorofhumanorganiccationtransporter2bymachinelearningbasedqsarmodel
AT manamiueno identificationofdequaliniumasapotentinhibitorofhumanorganiccationtransporter2bymachinelearningbasedqsarmodel
AT masahirookuda identificationofdequaliniumasapotentinhibitorofhumanorganiccationtransporter2bymachinelearningbasedqsarmodel